Analysis of the pathological implications of the abnormal accumulation of glycog...
Analysis of the pathological implications of the abnormal accumulation of glycogen in specific cell types
Glucose is stored in specialized tissues (mainly liver and muscle) in the form of a branched polymer called glycogen. Glycogen Synthase is the only enzyme able to catalyze this polymerization and its two isoforms (LGS and MGS) are...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BFU2017-84345-P
NUEVA VISION DEL METABOLISMO DEL GLUCOGENO
352K€
Cerrado
BFU2011-30554-C02-01
LUCES Y SOMBRAS DEL GLUCOGENO: ALTERACIONES EN EL METABOLISM...
474K€
Cerrado
GLYCOPHAGEAPP
Development of GlycoPhage Arrays as a novel high throughput...
100K€
Cerrado
SAF2009-11289
INVESTIGACION SOBRE LAS CAUSAS MOLECULARES Y ESTRATEGIAS TER...
48K€
Cerrado
SAF2009-07559
ESTUDIO DE LOS MECANISMOS DE DISFUNCIONALIDAD DEL PROCESO ME...
206K€
Cerrado
GENETICS OF T1D
Using gene to phenotype studies to identify type 1 diabetes...
50K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Glucose is stored in specialized tissues (mainly liver and muscle) in the form of a branched polymer called glycogen. Glycogen Synthase is the only enzyme able to catalyze this polymerization and its two isoforms (LGS and MGS) are mainly expressed in liver and in muscle, respectively. However, MGS is also expressed in all other tissues, regardless of their limited capacity to produce Glycogen. MGS activity is tightly controlled by several mechanisms. Recent results from the receiving group show that demise of these mechanisms in neurons causes apoptosis and may be the cause of Lafora disease. Our working hypothesis is that deregulation of MGS protein levels and/or activity is causative of several pathologies. Therefore, we aim to dissect the consequences of the loss of regulation of MGS in several cell types and tissues, using a state-of-the-art genetic approach. Our results will bring new evidence for the understanding of many unresolved human health conditions, and help to identify potential therapeutical strategies. The specific research objectives are: 1. To elucidate the mechanism by which the accumulation of glycogen triggers apoptosis. 2. To study whether aberrant accumulation of glycogen is responsible for some degenerative conditions. 3. To establish whether GS has a moonlighting function. These questions will be addressed both in vitro, using cell culture and diverse cell biology techniques, and in vivo, using newly available conditional mouse models. The applicant will join a group of reference in the study of the metabolism of glycogen, and will offer his extensive experience in the generation and use of mouse models for human disease. It is the applicant’s aim to become a skilled, independent research manager, either as a group leader or as scientific manager for research institutions. This project will provide the applicant with excellent scientific and managerial training opportunities.